Jakura, also known as tofacitinib, in its 5mg dosage, represents a significant breakthrough in the treatment of rheumatoid arthritis (RA). This taken by mouth medication, a specific Janus kinase (JAK) inhibitor, works by suppressing the signaling pathways that contribute to inflammation and joint damage characteristic of RA. Unlike traditional dise